Lessons from B(R)ICS: An effective and scaled-up AIDS response

Dirceu Greco, director of the department of STD, AIDS and viral hepatitis of the Brazilian Ministry of Health, at the International AIDS Conference. Photo by: © Ryan Rayburn / IAS

How can Brazil, South Africa, India and China contribute to the global AIDS response?

This was the topic of discussion at one of the major sessions on day three of the International AIDS Conference in Washington, D.C. Health officials from these emerging economies shared how their countries were able to scale up HIV treatment and prevention. Three things were made clear:

These four countries have been able to make significant gains in the fight against HIV and AIDS. South Africa has now been able to put 1.7 million people on antiretroviral therapy and reduce the rate of mother-to-child HIV transmissions from 8 percent in 2008 to 2.7 percent as of last week. Before the severe acute respiratory syndrome outbreak in 2003, most of China’s resources for AIDS programs came from international funding. Now, the Chinese government funds 80 to 90 percent of the country’s total AIDS budget.

In Brazil, a law mandating everyone who needs antiretroviral therapy should be given medicines was passed in 1996. Since then, Brazil has been able to make available 20 types of antiretroviral drugs, of which 10 are produced locally. All of the country’s funding to HIV treatment and prevention came only from taxes.

Dirceu Greco, director of the department of STD, AIDS and viral hepatitis of the Brazilian Ministry of Health, also had this to say: People should see how Brazils’ unified public health system works and see if it can be done in other countries.

Meanwhile, several other sessions and panel discussions were held.

Among the issues discussed at the Challenges and Solutions plenary session is translating scientific advances on HIV treatment and prevention into affordable health programs that can be adopted even in resource-limited settings. Antiretroviral therapy is one example. While the treatment can stop the progression of HIV and reduce transmission, experts continue to debate when therapy should start and what kind of regimen should be given.

The global economic slump has resulted in declining donor funding for HIV and AIDS. So how should aid agencies and recipients maximize the resources they are given? Presentations from the Joint U.N. Program on HIV/AIDS, the Office of the U.S. Global AIDS coordinator, Tanzania and Zimbabwe attempt to offer suggestions for strategic use of resources.

Funding isn’t just the only resource that’s become increasingly scarce. There is now a global shortage of “qualified and available” HIV health personnel, especially in Africa: The Global Health Workforce Alliance says 1 billion people do not have access to a skilled health worker, while the World Health Organization estimates 4 million additional health workers are needed.

But, the HIV and AIDS fight can’t be won through a purely medical approach. This was the argument International Development Law Organization’s Naomi Burke-Shyne made in a guest op-ed she penned for Devex Tuesday (July 24). This is also the topic of discussion at a session that talked about the findings and recommendations of the Global Commission on HIV and the Law. While there are good laws that help in the fight against HIV, there is an “epidemic of bad laws” and that a “comprehensive and humane approach to law reform” is needed to effectively protect the rights of HIV-positive people.

Here’s what else transpired on the third day of the international conference, along with a few essential reads.

Read more:

Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.